Vivopath Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Grant

  • Investors
  • 1

Vivopath General Information

Description

Owner and operator of a preclinical contract research organization intended to develop therapeutics for metabolic and inflammatory diseases. The company's services focus on offering comprehensive evaluation of novel compounds from formulation through preclinical in vivo proof-of-concept, enabling biotechnological companies and medical research firms to facilitate early drug discovery and in vivo proof-of-concept testing and develop new therapeutic treatments for metabolic and inflammatory disease.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Corporate Office
  • Redstone Center
  • 55 Union Street
  • Worcester, MA 01608
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
  • Redstone Center
  • 55 Union Street
  • Worcester, MA 01608
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivopath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2016 Completed Generating Revenue
2. Merger/Acquisition 01-Jun-2014 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2008 Completed Generating Revenue
To view Vivopath’s complete valuation and funding history, request access »

Vivopath Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Massachusetts Biomedical Initiatives Accelerator/Incubator
To view Vivopath’s complete investors history, request access »

Vivopath FAQs

  • When was Vivopath founded?

    Vivopath was founded in 2008.

  • Where is Vivopath headquartered?

    Vivopath is headquartered in Worcester, MA.

  • What industry is Vivopath in?

    Vivopath’s primary industry is Biotechnology.

  • Is Vivopath a private or public company?

    Vivopath is a Private company.

  • What is Vivopath’s current revenue?

    The current revenue for Vivopath is .

  • Who are Vivopath’s investors?

    Massachusetts Biomedical Initiatives has invested in Vivopath.

  • When was Vivopath acquired?

    Vivopath was acquired on 01-Jan-2016.

  • Who acquired Vivopath?

    Vivopath was acquired by Charles River Laboratories International.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »